Pictet Asset Management Holding Sa Xenon Pharmaceuticals Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,528,814 shares of XENE stock, worth $64.9 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,528,814
Previous 1,479,491
3.33%
Holding current value
$64.9 Million
Previous $57.7 Million
4.29%
% of portfolio
0.07%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding XENE
# of Institutions
212Shares Held
70.2MCall Options Held
88.3KPut Options Held
28.8K-
Avoro Capital Advisors LLC New York, NY5.67MShares$241 Million3.36% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.6MShares$195 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$163 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.71MShares$115 Million3.02% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$115 Million9.03% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.64B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...